Uracil/tegafur plus oral leucovorin does not affect survival rates but may be better tolerated than standard fluorouracil and leucovorin for previously untreated metastatic colorectal cancer.
Stabuc
Borut
B
Department of Gastroenterology, University Medical Center Ljubljana, Slovenia. borut.stabuc@kclj.si